Differential gene expression profiles in poor vs good responders to maintenance vinflunine in patients (p) with advanced urothelial carcinoma (aUC): Preliminary results of biomarker analyses from the MAJA trial (SOGUG 2011/02)

被引：0
|
作者：
Ramirez, J. L. [1 ]
Font Pous, A. [2 ]
Garcia-Donas, J. [3 ]
Perez Valderrama, B. [4 ]
Aguirre Egana, I. [5 ]
Nonell, L. [6 ]
de Porras Fontdevila, V. Ruiz [7 ]
Mallo, M. [8 ]
Balana, D. [1 ]
Virizuela, J. A. [9 ]
Anido, U. [10 ]
Llorente Ostiategui, M. M. [11 ]
del Alba Baamonde, M. A. Gonzalez [12 ]
Lainez, N. [13 ]
Mellado, B. [14 ]
Climent Duran, M. A. [15 ]
Bellmunt, J. [16 ]
机构：
[1] Germans Trias i Pujol Hlth Sci Res Inst IGTP, Catalan Inst Oncol ICO, Canc Mol Biol Lab, Badalona, Spain
[2] Inst Catala Oncol, Med Oncol, Badalona, Spain
[3] Hosp Madrid Norte San Chinarro Ctr Integral Oncol, Genitourinary Ginecol Skin & Rare Tumors Unit, Madrid, Spain
[4] Hosp Univ Virgen del Rocio, Med Oncol, Seville, Spain
[5] Germans Trias i Pujol Hlth Sci Res Inst IGTP, Catalan Inst Oncol ICO, Programa Med Predict & Personalitzada Canc, Badalona, Spain
[6] Inst Hosp Mar Invest Med, Microarrays Anal Dept, Barcelona, Spain
[7] Germans Trias i Pujol Hlth Sci Res Inst IGTP, Catalan Inst Oncol ICO, Resistance Chemotherapy & Predict Biomarkers Dept, Badalona, Spain
[8] Germans Trias i Pujol Hlth Sci Res Inst IGTP, Catalan Inst Oncol ICO, Josep Carreras Leukaemia Res Inst, Badalona, Spain
[9] Hosp Virgen Macarena, Med Oncol, Seville, Spain
[10] CHU Santiago, Santiago, Spain
[11] Hosp Gen Elda, Oncol, Elda, Spain
[12] Hosp Univ Son Espases, Med Oncol, Palma de Mallorca, Spain
[13] Complejo Hosp Navarra, Med Oncol, Pamplona, Spain
[14] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
[15] Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain
[16] Hosp del Mar, Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128P
引用
收藏
页数：1
相关论文
共 6 条
  • [1] Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)-SOGUG 2011-02
    Bellmunt, Joaquim
    Perez Valderrama, Begona
    Font, Albert
    Antonio Virizuela, Juan
    Angel Climent, Miguel
    Hernando Polo, Susana
    Mellado, Begona
    Lainez, Nuria
    Gonzalez del Alba, Aranzazu
    Angel Arranz, Jose
    Villa Guzman, Jose Carlos
    del Mar LLorente, Maria
    Castellano, Daniel E.
    Gallardo, Enrique
    Garcia del Muro, Xavier
    Anido, Urbano
    Domenech, Montserrat
    Puente, Javier
    Perez Gracia, Jose Luis
    Garcia-Donas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02
    Perez-Valderrama, B.
    Font, A.
    Virizuela Echaburu, J. A.
    Hernando, S.
    Climent, M. A.
    Arranz Arija, J.
    Villa Guzman, J. C.
    Llorente, M.
    Lainez Milagro, N.
    Mellado, B.
    Gonzalez del Alba, A.
    Gallardo, E.
    Castellano, D.
    Anido, U.
    Domenech, M.
    Garcia del Muro, X.
    Puente, J.
    Morales, R.
    Bellmunt, J.
    Garcia-Donas, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Randomized, placebo-controlled phase II trial (MAJA) Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC)-SOGUG 2011-02
    Font, Albert
    Perez-Valderrama, Begona
    Virizuela, Juan Antonio
    Polo, Susana Hernando
    Climent, Miguel Angel
    Arija, Jose Angel Arranz
    Guzman, Jose Carlos Villa
    del Mar LLorentet, Maria
    Lainez, Nuria
    Mellado, Begona
    del Alba, Aranzazu Gonzalez
    Diaz, Enrique Gallardo
    Castellano, Daniel
    Herranz, Urbano Anido
    Domenech, Montserrat
    del Muro, Xavier Garcia
    Puente, Javier
    Morales, Rafael
    Garcia-Donas, Jesus
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlled phase II trial. SOGUG 2011-02. EudraCT 2011-001271-39
    Donas Jimenez, J. Garcia
    Perez Valderrama, B.
    Font Pous, A.
    Virizuela Echaburu, J. A.
    Climent Duran, M. A.
    Hernando Polo, S.
    Mellado Gonzalez, B.
    Lainez Milagro, N.
    del Alba Baamonde, M. A. Gonzalez
    Arranz Arija, J. A.
    Villa Guzman, J. C.
    Llorente Ostiategui, M. D. M.
    Castellano Gauna, D.
    Gallardo Diaz, E.
    del Muro Solans, X. Garcia
    Anido Herranz, U.
    Domenech Santasusana, M.
    Puente Vazquez, J.
    Perez Gracia, J. L.
    Bellmunt Molins, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S524 - S525
  • [5] Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
    Garcia-Donas, Jesus
    Font, Albert
    Perez-Valderrama, Begona
    Antonio Virizuela, Jose
    Angel Climent, Miquel
    Hernando-Polo, Susana
    Angel Arranz, Jose
    del Mar Llorente, Maria
    Lainez, Nuria
    Carlos Villa-Guzman, Jose
    Mellado, Begona
    Gonzalez del Alba, Aranzazu
    Castellano, Daniel
    Gallardo, Enrique
    Anido, Urbano
    Garcia del Muro, Xavier
    Domenech, Montserrat
    Puente, Javier
    Morales-Barrera, Rafael
    Luis Perez-Gracia, Jose
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2017, 18 (05): : 672 - 681
  • [6] Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial (vol 18, pg 672, 2017)
    Garcia-Donas, J.
    Font, A.
    Perez-Valderrama, B.
    LANCET ONCOLOGY, 2019, 20 (01): : E9 - E9
1